Glaucoma cannot be cured, which is why there is great interest among patients, physicians, and scientists in new regenerative therapies for the disease. The clinical application of stem cell therapy holds great promise. Recent reports of patient-funded trials, where the patient pays to participate in a study and receive experimental stem cell treatments for glaucoma, [Read More]
Glaucoma is known as one of the most common causes of vision loss and blindness in older Americans. Despite its prevalence, there is still no cure for it. While treatments can prevent the disease from worsening, nothing can reverse the damage caused by glaucoma. Scientists are now studying the applications of regenerative medicine to determine [Read More]
With an eye on the future, the International Glaucoma Association and the UK and Eire Glaucoma Society have released funding to Professor Colin Willoughby and Dr. Carl Sheridan of the University of Liverpool’s Institute of Ageing and Chronic Diseases. This stimulus fund will be used to develop stem cell treatments for glaucoma. The type of [Read More]
The eye is an incredible and complex piece of anatomy, which means it stands the risk of malfunctioning or becoming injured at any time. Glaucoma is one such disease that can cause vision loss and blindness, but stem cell research recently uncovered a potential method to overcome the disease and help prevent or even cure [Read More]
